|
CTRVP Hepion Pharmaceuticals Inc Preferred Shares 1583771 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-810,791.00 |
| Balance Sheet |
|
Current Assets
|
$2,705,503.00 |
|
Assets
|
$2,705,503.00 |
|
Current Liabilities
|
$735,572.00 |
|
Liabilities
|
$848,747.00 |
|
Equity
|
$1,856,756.00 |
|
Shares Out
|
11620317.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$578,584.00 |
|
Investing Cash Flow
|
$-132,117.00 |
| Market Analysis |
Market Cap
|
$1,611,748.00 |
|
BVPS
|
0.16 |
|
PB
|
4.22 |
|
EPS
|
-0.07 |
|
FCF
|
$564,280.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:32:02 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:02:08 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CTRVP documents filed with the SEC.
CTRVP Filings
Clear
